Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
![23_01_BPO_BusBiotech_1200x628_Ep156 23_01_BPO_BusBiotech_1200x628_Ep156](https://vertassets.blob.core.windows.net/image/5a3d1ee7/5a3d1ee7-4136-450f-bfce-c852bd913abe/375_250-23_01_bpo_busbiotech_1200x628_ep156.png)
Ahmed Hamdy, MD didn’t ask to be the subject of Nathan Vardi's new book For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug.
In fact, that particular chapter of Dr. Hamdy’s career is one he’d rather not relive. But, in display of the resilience required of biotech leadership, Hamdy made a raging comeback. On this week’s episode of the Business of Biotech, we dive into Hamdy’s resurrection; how he shepherded Acerta Pharma all the way to a multibillion dollar blockbuster exit with Astra Zeneca and his plans to recreate that success in his new post as CEO and Founder at cancer therapeutics-focused Vincerx Pharma.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.